Editorial
NEJM at ESC — Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy
New England Journal of Medicine · 02.01.2025 · 392 (1)
DOI: 10.1056/nejme2410890 ↗Kurz gefasst
Editorial in der Zeitschrift New England Journal of Medicine, erschienen am 02.01.2025. Verfasst von Eric J Rubin und 2 weiteren Autor:innen. Die Arbeit wurde bisher 11-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Rubin, E. J., Leopold, J., & Morrissey, S. (2025). NEJM at ESC — Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy. New England Journal of Medicine, 392(1). https://doi.org/10.1056/nejme2410890
Vancouver
Rubin EJ, Leopold J, Morrissey S. NEJM at ESC — Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy. New England Journal of Medicine. 2025;392(1). doi:10.1056/nejme2410890
BibTeX
@article{Rubin2025,
author = {Rubin, Eric J and Leopold, Jane and Morrissey, Stephen},
title = {NEJM at ESC — Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy},
journal = {New England Journal of Medicine},
year = {2025},
volume = {392},
number = {1},
doi = {10.1056/nejme2410890}
}
EUVIMED